History Says Johnson & Johnson Beats Medtronic. Here's Why I'd Still Consider MDT for the Next Decade.
Medtronic is following a strategy that has worked well for Johnson & Johnson.
Overview
Johnson & Johnson's (NYSE:JNJ) stock has absolutely crushed Medtronic's (NYSE:MDT) over the last decade. The iconic healthcare giant has generated a nearly 200% total return over the last 10 years (11.6% annualized), compared with roughly 35% for the healthcare technology company (3.1% annualized).
However, while Johnson & Johnson's stock was the clear winner over the past decade, I think Medtronic could be the better investment over the next 10 years. Here's why.
Image source: Getty Images.
Details
Source
Originally published at www.fool.com.
Related Articles
Disclaimer: This article is for informational purposes only and does not constitute investment advice. Data may be delayed up to 15 minutes. Past performance is not indicative of future results. Consult a licensed financial advisor before making investment decisions.